TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CASI PHARMS INC

Pharmaceuticals
Generics

CASI PHARMS INC is a generic drug manufacturer with 1 FDA-approved products.

2011
Since
1
Drugs
-
Trials
13
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2025-09-24
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-04-09
Labeling
HEPARIN SODIUM 2025-02-04
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
HEPARIN SODIUM 2024-10-24
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...